Henderson Patterson bodies

Posaconazole
• blocks the synthesis of
ergosterol, a key component
of the fungal cell membrane
• New delayed release tablet
(100mg) and injectable
formulations now approved
by FDA for clinical use
• New delayed release tablet
(100mg) and injectable
formulations now approved
by FDA for clinical use
• Minimal active drug is
excreted in the urine like
Voriconazole, posaconazole
Amphotericin B